Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.
2.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

3.
4.

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.

Schrier RW, Estacio RO, Mehler PS, Hiatt WR.

Nat Clin Pract Nephrol. 2007 Aug;3(8):428-38. Review.

PMID:
17653121
5.

Improving microvascular outcomes in patients with diabetes through management of hypertension.

McGill JB.

Postgrad Med. 2009 Mar;121(2):89-101. doi: 10.3810/pgm.2009.03.1980. Review.

PMID:
19332966
6.

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C.

BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169. Review.

7.

New treatment guidelines for a patient with diabetes and hypertension.

Mogensen CE.

J Hypertens Suppl. 2003 Mar;21(1):S25-30. Review.

PMID:
12769164
8.
9.

Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

Komers R, Anderson S.

Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. Review.

PMID:
10757223
10.
11.

Beta-blockers and diabetes: the bad guys come good.

Cruickshank JM.

Cardiovasc Drugs Ther. 2002 Sep;16(5):457-70. Review.

PMID:
12652116
12.

What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons.

Standl E, Erbach M, Schnell O.

Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:60-6. doi: 10.1002/dmrr.2355. Review.

PMID:
23280868
13.
14.

Medical management of diabetic retinopathy: an overview.

Malek M, Khamseh ME, Aghili R, Emami Z, Najafi L, Baradaran HR.

Arch Iran Med. 2012 Oct;15(10):635-40. Review.

PMID:
23020540
15.

Treating high-risk diabetic hypertensive patients with comorbid conditions.

Schrier RW.

Am J Kidney Dis. 2000 Sep;36(3 Suppl 1):S10-7. Review.

PMID:
10986154
16.

Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials.

Buehler AM, Cavalcanti AB, Berwanger O, Figueiro M, Laranjeira LN, Zazula AD, Kioshi B, Bugano DG, Santucci E, Sbruzzi G, Guimaraes HP, Carvalho VO, Bordin SA.

Cardiovasc Ther. 2013 Jun;31(3):147-60. doi: 10.1111/j.1755-5922.2011.00308.x. Epub 2011 Dec 29. Review.

PMID:
22212499
17.
18.

Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.

Cerveny JD, Leder RD, Weart CW.

Ann Pharmacother. 1998 Sep;32(9):896-905. Review.

PMID:
9762378
19.

New frontiers in the management of type 2 diabetes.

Mudaliar S.

Indian J Med Res. 2007 Mar;125(3):275-96. Review.

PMID:
17496356
20.

Supplemental Content

Support Center